CRISPR-Cas9 Mediated Epigenetic Reprogramming of Cardiac Fibroblasts as a Therapeutic Strategy for Post-Infarction Myocardial Remodeling. ISCSITR-IJMSRD [Internet]. 2024 Feb. 20 [cited 2025 Jul. 24];5(2):1-9. Available from: https://iscsitr.in/index.php/ISCSITR-IJMSRD/article/view/ISCSITR-IJMSRD_05_02_001